Endothelin antagonists in diabetic nephropathy: back to basics
- PMID: 24722443
- PMCID: PMC4005324
- DOI: 10.1681/ASN.2014020174
Endothelin antagonists in diabetic nephropathy: back to basics
Keywords: cell signaling; chronic kidney disease; diabetic; endothelin antagonists; glomerulosclerosis; nephropathy; podocyte.
Comment on
-
HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.J Am Soc Nephrol. 2014 May;25(5):1073-82. doi: 10.1681/ASN.2013050482. Epub 2014 Mar 7. J Am Soc Nephrol. 2014. PMID: 24610925 Free PMC article.
-
Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.J Am Soc Nephrol. 2014 May;25(5):1050-62. doi: 10.1681/ASN.2013020195. Epub 2014 Apr 10. J Am Soc Nephrol. 2014. PMID: 24722437 Free PMC article.
References
-
- Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988 - PubMed
-
- Barton M, Yanagisawa M: Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 86: 485–498, 2008 - PubMed
-
- Lüscher TF, Barton M: Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102: 2434–2440, 2000 - PubMed
-
- Kitamura K, Tanaka T, Kato J, Eto T, Tanaka K: Regional distribution of immunoreactive endothelin in porcine tissue: Abundance in inner medulla of kidney. Biochem Biophys Res Commun 161: 348–352, 1989 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
